Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Xue‐Yan Jiang"'
Autor:
Ke-Xin Li, Jia-Ru Li, Sheng-Jia Zuo, Xudong Li, Xian-Tong Chen, Pei-Yi Xiao, Hui-Tao Li, Ling Sun, Tao Qian, Hao-Min Zhang, Dongxing Zhu, Xi-Yong Yu, Guojun Chen, Xue-Yan Jiang
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-24 (2024)
Abstract Background Congenital heart disease (CHD) is a prevalent congenital cardiac malformation, which lacks effective early biological diagnosis and intervention. MicroRNAs, as epigenetic regulators of cardiac development, provide potential biomar
Externí odkaz:
https://doaj.org/article/9abde8e38db141908e0685e592b82b14
Autor:
Lin‐Ping Zhao, Rong‐Rong Zheng, Xiao‐Na Rao, Chu‐Yu Huang, Hang‐Yu Zhou, Xi‐Yong Yu, Xue‐Yan Jiang, Shi‐Ying Li
Publikováno v:
Advanced Science, Vol 11, Iss 15, Pp n/a-n/a (2024)
Abstract The chemo‐regulation abilities of chemotherapeutic medications are appealing to address the low immunogenicity, immunosuppressive lactate microenvironment, and adaptive immune resistance of colorectal cancer. In this work, the proteolysis
Externí odkaz:
https://doaj.org/article/5ef7f403debb46febbbad265cd7bd424
Autor:
Tao-Ran Li, Yun-Xia Yao, Xue-Yan Jiang, Qiu-Yue Dong, Xian-Feng Yu, Ting Wang, Yan-Ning Cai, Ying Han
Publikováno v:
Alzheimer’s Research & Therapy, Vol 14, Iss 1, Pp 1-13 (2022)
Abstract Background Blood biomarkers that can be used for preclinical Alzheimer’s disease (AD) diagnosis would enable trial enrollment at a time when the disease is potentially reversible. Here, we investigated plasma neuronal-derived extracellular
Externí odkaz:
https://doaj.org/article/744b446c196f4ababa7cd0da720cc870
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-12 (2021)
Abstract Introduction Subjective cognitive decline (SCD) represents a cognitively normal state but at an increased risk for developing Alzheimer’s disease (AD). Recognizing the glucose metabolic biomarkers of SCD could facilitate the location of ar
Externí odkaz:
https://doaj.org/article/e061744c14f74dcdbe0b64003b89ddd3
Autor:
Tao-Ran Li, Qiu-Yue Dong, Xue-Yan Jiang, Gui-Xia Kang, Xin Li, Yun-Yan Xie, Jie-Hui Jiang, Ying Han
Publikováno v:
NeuroImage: Clinical, Vol 33, Iss , Pp 102900- (2022)
Objective: Disease-related metabolic brain patterns have been verified for a variety of neurodegenerative diseases including Alzheimer’s disease (AD). This study aimed to explore and validate the pattern derived from cognitively normal controls (NC
Externí odkaz:
https://doaj.org/article/0d0534d2d3c44d2697a373dec556885f
Autor:
Xue-Yan Jiang, Yu-Liang Feng, Li-Tong Ye, Xiao-Hong Li, Juan Feng, Meng-Zhen Zhang, Harnath S. Shelat, Michael Wassler, Yangxin Li, Yong-Jian Geng, Xi-Yong Yu
Publikováno v:
Stem Cell Reports, Vol 8, Iss 2, Pp 290-304 (2017)
Maternal nicotine exposure causes alteration of gene expression and cardiovascular programming. The discovery of nicotine-medicated regulation in cardiogenesis is of major importance for the study of cardiac defects. The present study investigated th
Externí odkaz:
https://doaj.org/article/47663bfbb8d945daa6667a118cf37351
Autor:
Gui-Ling Fan, Hong Cheng, A-Li Chen, Shi-Ying Li, Ping Yuan, Ai-Hua Hu, Lin-Ping Zhao, Xue-Yan Jiang, Xi-Yong Yu, Fu-An Deng, Ling-Shan Liu
Publikováno v:
Acta Biomaterialia. 117:349-360
Development of antitumor agents with high efficiency and low toxicity is one of the most important goals for biomedical research. However, most traditional therapeutic strategies were limited due to their non-specificity and abnormal tumor microenvir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::523f0d3c2aeccc4dcedc676a55105f4f
https://doi.org/10.1016/j.actbio.2020.09.047
https://doi.org/10.1016/j.actbio.2020.09.047
Autor:
Yuyan Qin, Lingmin Zhang, Xinke Zhou, Xue-Yan Jiang, Xiantong Chen, Xiaoya Zhao, Xi-Yong Yu, Jianglin Wang, Shengjia Zuo, Lixin Zhao, Lin Zhongxiao
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 10, Iss 2, Pp 313-326 (2020)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Overexpression of exogenous lineage-determining factors succeeds in directly reprogramming fibroblasts to various cell types. Several studies have reported reprogramming of fibroblasts into induced cardiac progenitor cells (iCPCs). CRISPR/Cas9-mediat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc03a272fe4a589be805abdf3df98b59
http://www.sciencedirect.com/science/article/pii/S2211383519305969
http://www.sciencedirect.com/science/article/pii/S2211383519305969
BRD9 controls the oxytocin signaling pathway in gastric cancer via CANA2D4, CALML6, GNAO1, and KCNJ5
Publikováno v:
Translational Cancer Research
Background First-line chemotherapeutic agents lead to remarkable activation treatment in cancers, but the side effects of these drugs also damage healthy cells. In some cases, drug resistance to chemotherapeutic agents is induced in cancer cells. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d5048a0a8830afa078a024cf34acfb
http://europepmc.org/articles/PMC8798819
http://europepmc.org/articles/PMC8798819
Publikováno v:
Alzheimer's research & therapy 13(1), 74 (2021). doi:10.1186/s13195-021-00811-w
Alzheimer's Research & Therapy
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-12 (2021)
Alzheimer's Research & Therapy
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-12 (2021)
Introduction Subjective cognitive decline (SCD) represents a cognitively normal state but at an increased risk for developing Alzheimer’s disease (AD). Recognizing the glucose metabolic biomarkers of SCD could facilitate the location of areas with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::719a5e4fb61be0ba336fa2a462861314
https://doi.org/10.1186/s13195-021-00811-w
https://doi.org/10.1186/s13195-021-00811-w